Table 3.
Study | Prevalence of Dry Socket in All Patients [%] | Prevalence of Dry Socket in Smokers [%] | Tooth Extracted | Extraction Technique | Symptoms Recognised as the Onset of Dry Socket | Provided Prophylaxis or Treatment |
---|---|---|---|---|---|---|
Al-Belasy, 2004 [21] | 11.5 | 16.0 | 100% impacted mandibular third molars | 100% atraumatic extractions | constant radiating pain not relieved by the analgesic, accompanied by a denuded socket or necrotic clot and a fetid smell | postoperative medications given orally for analgesia were naproxen or diflunisal at a dose of 500 mg twice daily; if dry socket was diagnosed, sockets were irrigated with saline and packed with a eugenol-iodoform dressing |
Alsaleh et al., 2018 [22] | 7.0 | 9.4 | all teeth except retained third molars | single tooth extractions | severe pain at the extraction site within 3 days, no blood clot at the extraction site, visible bone at the extraction site, bad breath, bad taste in mouth | patients were given post-extraction instructions verbally after the extraction |
Bortoluzzi et al., 2012 [23] | 1.3 | 2.7 | all kinds of fully erupted teeth | 12% traumatic extractions, 88% simple extractions | NR | NR |
Eshghpour & Nejat, 2013 [24] | 25.9 | 35.1 | 100% impacted mandibular third molars | 100% traumatic extractions | 1 to 3 days after extraction with severe pain, halitosis, foul taste, and regional lymphadenitis; no blood clot in the socket and the bone is exposed | flap sutured using 3-0 silk suture; regimen of amoxicillin (500 mg) and Gelofen (400 mg cap, TID, for maximum 3 days) was prescribed |
Halabí et al., 2012 [25] | 6.1 | 57.9 | 93.6% maxillary, 6.4% mandibular | 4.9% traumatic extractions, 95.1% simple extractions | increasing postoperative pain intensity for 4 days within and around the socket and/or total or partial breakdown of the blood clot in the socket with or without bone exposure | reported measures for alleviating alveolar osteitis in high-risk patients include local treatment with tetracycline or preoperative and 7-day postoperative rinsing with 0.12% chlorhexidine |
Heng et al., 2007 [26] | 5.0 | 6.7 | 83.1% maxillary, 16.9% mandibular | 27.9% traumatic extractions, 72.1% simple extractions | alveolar osteitis, pain, swelling, bleeding | patients received a verbal and written postoperative recommendation, usually ibuprofen as an analgesic; for postoperative complaints, patients had open access to the clinic |
López-Carriches et al., 2006 [27] | 3.1 | 6.5 | 100% lower third molar | NR | wound appearance and condition were assessed in terms of colour, marginal swelling, ulceration, the presence of plaque | no antibiotic treatment was prescribed postoperatively, and the patients received only metamizole as analgesic treatment, diclofenac was also prescribed as antiinflammatory treatment |
Momeni et al., 2011 [28] | 0.6 | 0.6 | 36.3% maxillary, 63.7% mandibular | NR | throbbing pain, oral malodour, and unpleasant taste; onset of symptoms 42–72 h after tooth extraction and there is no redness or purulent discharge at the affected sites | palliative intervention with prescribing anti-inflammatory drugs |
Parthasarathi et al., 2011 [29] | 4.2 | 4.6 | 38.8% maxillary, 61.2% mandibular | 17% traumatic extractions, 83% simple extractions | the patient’s history of pain and the presence of exposed bone, intraorally | NR |
Schwartz-Arad et al., 2018 [30] | 11.7 | 33.3 | 100% third molar extraction | NR | NR | all patients were prescribed oral antibiotics (amoxicillin 1.5 g for 5 days) or clindamycin (1.2 mg for 4 days), and dexamethasone (4 mg for 2 days); rinsing with 0.25% chlorohexidine continued twice a day for 10 days after extraction; naproxen was provided as a nonsteroidal anti-inflammatory drug twice a day |
Vettori et al., 2019 [31] | 3.2 | 5.5 | 51% maxillary, 49% mandibular | 15.7% traumatic extractions, 84.3% simple extractions | NR | almost all surgical sites had been sutured, in 10.47% of cases the patient had started an antibiotic therapy before the intervention; after the intervention, the surgeon prescribed antibiotic therapy to 9.23% of patients, steroids to 0.24% of patients, NSAIDs to 3% of patients |
Legend: NR, not reported; TID, three times a day; NSAIDs, non-steroidal anti-inflammatory drugs.